Complete Mounjaro To Wegovy Conversion Guide Available Now
Mounjaro To Wegovy Dose Conversion Chart: UK Stock Availability
The key advantage of choosing Wegovy through EverydayMeds is our Stock Available availability across all five licensed doses. Unlike the historical supply shortages that affected Wegovy availability in 2023, our direct relationship with Novo Nordisk ensures consistent inventory levels. When converting from Mounjaro to Wegovy, you'll typically restart with the 0.25mg dose regardless of your previous Mounjaro strength, as the dose escalation schedules differ significantly between these medications.
Our current stock levels include starter doses (0.25mg), progression strengths (0.5mg, 1mg, 1.7mg), and maintenance doses (2.4mg), all stored under MHRA-compliant cold-chain conditions. This comprehensive availability means you can complete your entire Wegovy dose escalation journey without interruption, avoiding the frustrating delays that have historically affected UK patients seeking weight management support.
Wegovy Pricing Structure For Mounjaro To Wegovy Dose Conversion
Converting from Mounjaro to Wegovy starts with our competitively priced starter dose at £79.99 for the 0.25mg pen when using code FIRST40 at checkout. The complete dose escalation pricing includes 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the maintenance 2.4mg dose at £209.99. These prices represent exceptional value compared to private clinic consultations, which often charge consultation fees in addition to medication costs.
For patients planning their complete conversion journey, our Getting Started bundles provide convenient multi-dose packages. The Intro Duo (0.25mg and 0.5mg) costs £169.99, while the Intro Trio (0.25mg, 0.5mg, and 1mg) is priced at £299.99. Returning customers benefit from the DOSE25 discount code, and all orders include complimentary next-day cold-chain delivery to ensure medication integrity during transit.
Clinical Evidence Supporting Mounjaro To Wegovy Dose Conversion Decisions
The STEP clinical trial programme, particularly the landmark STEP 1 study published by Wilding et al. in the New England Journal of Medicine (2021), demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks. This evidence base supports Wegovy as an effective option for patients transitioning from other weight management medications, including Mounjaro.
Recent cardiovascular outcome data from the SELECT trial showed a 20% reduction in major cardiovascular events among patients taking Wegovy, providing additional clinical rationale for conversion decisions. These trial results inform prescriber recommendations when evaluating patient suitability for Mounjaro to Wegovy conversion, particularly for individuals with existing cardiovascular risk factors.
Understanding Wegovy Mechanism For Mounjaro Conversion Planning
Wegovy functions as a selective GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and food intake. Unlike Mounjaro's dual mechanism targeting both GIP and GLP-1 receptors, Wegovy specifically activates GLP-1 receptors in the brain's appetite control centres. This targeted approach may help reduce food cravings and promote earlier satiety after smaller meals. The once-weekly injection schedule using Novo Nordisk's FlexTouch pen device provides consistent medication exposure throughout the conversion period. When transitioning from Mounjaro's dual-agonist mechanism to Wegovy's GLP-1-only approach, patients typically experience continued appetite suppression, though individual responses may vary during the initial conversion weeks.
Streamlined Ordering Process For Mounjaro To Wegovy Dose Conversion
Converting from Mounjaro to Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, specifically designed to evaluate your current medication history and conversion suitability. Our clinical team, operating under GPhC registration #9012878, reviews your assessment within 3 working days (or 24 hours with express service) to ensure safe conversion protocols. Once approved, your Wegovy prescription is dispensed from our temperature-controlled pharmacy facility and dispatched via next-day cold-chain courier. The entire process from assessment completion to delivery typically takes 4-5 working days, ensuring minimal interruption to your weight management programme. Our clinical team remains available throughout the conversion period to address any questions about dose timing or administration technique.
Storage Requirements During Mounjaro To Wegovy Dose Conversion
Wegovy offers a significant practical advantage during the conversion process with its extended room temperature stability of up to 6 weeks once removed from refrigeration (below 30°C), compared to Mounjaro's 21-day room temperature limit. This enhanced stability provides greater flexibility for travel and daily routine management during your conversion period. Before first use, Wegovy should be stored in the refrigerator between 2-8°C, and the FlexTouch pen design ensures consistent dose delivery throughout the 4-week usage period. The mandatory dose escalation schedule (0.25mg for weeks 1-4, 0.5mg for weeks 5-8, continuing through to 2.4mg maintenance) cannot be accelerated, regardless of your previous Mounjaro dose strength. This gradual escalation helps minimise gastrointestinal side effects commonly experienced during GLP-1 medication transitions.
Conversion Timeline Management For Mounjaro To Wegovy Dose Chart Implementation
The optimal conversion strategy typically involves completing your current Mounjaro pen before initiating Wegovy at the 0.25mg starting dose, avoiding overlapping GLP-1 receptor agonist exposure. Our clinical team provides specific timing guidance based on your current Mounjaro dose and administration schedule, ensuring appropriate washout periods where clinically indicated. Stock availability across all Wegovy doses means your conversion timeline isn't disrupted by supply constraints that have previously affected UK weight management programmes.
Planning ahead with our bundle options ensures you have subsequent doses ready as you progress through the escalation schedule. The Intro Trio bundle provides your first 12 weeks of Wegovy doses in a single order, eliminating multiple prescription requests during the critical conversion period. This forward planning approach has proven particularly valuable for patients transitioning from Mounjaro, as it provides confidence that dose progression won't be interrupted by stock shortages.
Complete Your Mounjaro To Wegovy Dose Conversion Chart Today
EverydayMeds currently maintains full stock availability across all Wegovy doses, positioning us as the reliable choice for your Mounjaro to Wegovy conversion. New customers can start their conversion journey using discount code FIRST40, while returning patients benefit from the DOSE25 code applied at checkout. Our established supply chain partnership with Novo Nordisk ensures consistent availability throughout your dose escalation journey, and our GPhC #9012878 registration provides the clinical oversight necessary for safe medication transitions. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, and join thousands of UK patients who have successfully converted to Wegovy through our streamlined prescription service. Our clinical team combines medication expertise with practical conversion support, ensuring your transition from Mounjaro to Wegovy proceeds smoothly and effectively.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
